{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_polymer_monomers_monomerSubstance_refPname in Monomer Substance Name (approximate match)
Status:
US Approved OTC
Source:
21 CFR 349.12(a)(2) ophthalmic:demulcents hydroxyethylcellulose
Source URL:
First approved in 1941
Source:
NDA019516
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:paclitaxel obaluronate [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:aligomanuxic acid [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT00388700: Phase 2 Interventional Withdrawn Colorectal Cancer
(2006)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT00002100: Phase 1 Interventional Completed HIV Infections
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT01621243: Phase 1/Phase 2 Interventional Terminated Metastatic Pancreatic Cancer
(2012)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:diclofenac etalhyaluronate [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT02205840: Phase 2/Phase 3 Interventional Completed Dry Eye Syndromes
(2014)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03358810: Not Applicable Interventional Completed Dysphagia Following Cerebral Infarction
(2018)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT02515838: Phase 2 Interventional Completed Sickle-Cell Disease
(2015)
Source URL:
Class:
POLYMER
